Genetic Signatures Limited (ASX: GSS) held its 2017 Annual General Meeting on Tuesday 28 November 2017 at 11.00am (AEST).
- Dr. Damien Stark of (St. Vincent’s Pathology Sydney), presenting at upcoming NRL Workshop on Molecular Diagnostics, 15-16th October Melbourne, Australia
- Genetic Signatures exhibiting at ESCV 2018 Athens, Greece, 23-26 September
- Genetic Signatures exhibiting at the upcoming Sheffield Microbe 2018 Symposium, 21-23 September in Sheffield, UK.
- Date of 2018 Annual General Meeting of Shareholders (GSS: ASX)
- Genetic Signatures’ CEO Dr. John Melki interview by Proactive Investors
- Genetic Signatures article from The Australian Financial Review.
- Genetic Signatures’ CEO Dr. John Melki presenting at the inaugural ASX Small and Mid-Cap Conference 6th September, Sydney, Australia.
- Genetic Signatures (ASX:GSS) – Appendix 4E and 2018 Financial Report
- Genetic Signatures (ASX:GSS) – Appendix 4G and 2018 Corporate Governance Statement
- Genetic Signatures (ASX:GSS) – Additional Tax Incentive from understatement FY17 R&D Claim